The temporal relationships among sleep, depressive symptoms, and pain are unclear. This longitudinal study examines whether insomnia and sleep duration predict the onset of chronic multisite musculoskeletal pain over 6 years and whether this association is mediated by depressive symptoms. Methods: 1860 subjects of the Netherlands Study of Depression and Anxiety, free from chronic multisite musculoskeletal pain at baseline, were followed up for the onset of chronic multisite musculoskeletal pain over 6 years (Chronic Pain Grade Questionnaire). We determined baseline insomnia (Women's Health Initiative Insomnia Rating Scale ≥9) and sleep duration (short: ≤6 hr, normal: 7-9 hr, long: ≥10 hr). Depressive symptoms were assessed at baseline and as a change score over time (Inventory of Depressive Symptomatology 001) were associated with chronic pain onset. Adding baseline depressive symptoms as a mediator attenuated the associations for insomnia and short sleep with chronic pain onset (∆B = 40% and 26%, respectively). Adding the change score of depressive symptoms further weakened the association for insomnia (∆B = 16%) but not for short sleep. All direct effects for sleep measures with chronic pain onset remained statistically significant (p < .05).
INTRODUCTION
Chronic multisite musculoskeletal pain is common and highly disabling. 1, 2 Sleep complaints are found in 67%-88% of persons with chronic pain. 3, 4 Although the etiology underlying chronic pain remains largely unknown, poor sleep might contribute to the condition's development.
Individuals who suffer from sleep disturbances, such as insomnia, consistently show an increased risk for the future development of chronic pain. [5] [6] [7] [8] [9] [10] [11] One prospective study (n = 4140) showed that characteristics of insomnia, that is, difficulty initiating or maintaining sleep, early awakening and nonrestorative sleep, were associated with at higher risk of developing musculoskeletal pain over 12 months. 5 Although early work suggests that the relationship between disturbed sleep and pain may be bidirectional, [12] [13] [14] more recent findings have shown that the temporal effect of disturbed sleep on pain may be stronger than that of pain on sleep. 15, 16 Sleep disturbances might decrease pain thresholds and contribute to hypersensitivity of neural nocicep tive pathways, a process called central sensitization. 17 Several experimental studies in painfree subjects have shown that sleep deprivation leads to increased pain intensity evoked by nociceptive stimuli (hyperalgesia) or increased reports of pain severity. 12, [18] [19] [20] Normal sleep has previously been associated with decreased muscle tonus. 21 Reversely, disturbed sleep may possibly hamper natural muscle relaxation and recovery, which can ultimately result in chronic pain. 9 Research suggests that negative mood mediates the association between sleep disturbances and the development of chronic pain. 16 One previous study (n = 292), although cross-sectional of nature, indeed concluded that depressive symptoms mediated the association between disturbed sleep and pain among chronic pain patients. 22 Depressive symptoms may impact on pain possibly through mechanisms of increased physiologic or cognitive arousal and decreased physical activity. 22 Other studies suggest that sleep disturbances, depressive symptoms, and chronic pain may be mutually interactive. 17, 23 Nevertheless, there is little clarity on the temporal dynamics of disturbed sleep, depressive symptoms, and pain. This is mainly due to a lack of large-scale longitudinal studies that test whether sleep induces chronic pain beyond the influence of depressive symptoms and that adjust for covariates such as sociodemographic characteristics, lifestyle, and chronic disease.
This large-scale prospective study examines whether insomnia and sleep duration predict the onset of chronic multisite musculoskeletal pain over 6 years and whether this association is mediated by depressive symptoms.
METHODS

Sample
The present study used longitudinal data from the Netherlands Study of Depression and Anxiety (NESDA). NESDA is an ongoing cohort study in which 2981 participants (18-65 years and 67% female at baseline, 95% North-European ancestry) were monitored biannually for 6 years to investigate the long-term course and consequences of depressive and anxiety disorders. Participants were recruited from the community (19%), primary care (54%), and specialized mental health care (27%). People with and without psychiatric disorders and with and without chronic pain participated in the study. The disorders included dysthymia, major depressive disorder, general anxiety disorder, panic disorder, social phobia, and agoraphobia. Due to the aim of the NESDA study, exclusion criteria were not being fluent in Dutch and a primary diagnosis of psychotic, obsessive compulsive, bipolar, or severe addiction disorder. Baseline data collection took place between 2004 and 2007, with follow-up assessments 2, 4, and 6 years later. Using written questionnaires and a face-to-face interview, extensive information was gathered about demographic, clinical, and psychosocial characteristics by specially trained research staff at the research site. The research protocol was approved by the Ethical Committee of participating universities, and written informed consent was obtained from all participants. Penninx et al. 24 provided a detailed description of the NESDA study design and sampling procedures.
Subjects who were free of chronic multisite musculoskeletal pain at baseline (n = 2213; see subsequently) were selected. Of these eligible subjects, 2039 subjects had data on pain available for at least one follow-up measure (2, 4, or 6 years). From these subjects, we selected those who had baseline data on insomnia or sleep duration available, leaving a total of 1860 subjects for this study. Included subjects (n = 1860) had significantly lower pain duration and intensity scores at baseline, were significantly older, and had more years of education than eligible persons who had incomplete data (n = 353; all p < .05). Also, included subjects had higher levels of physical activity, had lower depressive symptoms scores at baseline and 2-year follow-up, were more often nonsmokers/former smokers, and were less often long sleepers at baseline (all p < .05) but did not differ in gender, body mass index, alcohol intake, the number of chronic diseases, insomnia, and short or normal sleep duration at baseline and depressive symptoms at 4-and 6-year follow-up (all p > .05) from excluded subjects (n = 353). From these 1860 included subjects, baseline data for insomnia were available of 1856 subjects, for sleep duration of 1859 subjects, and for baseline depressive symptoms of 1855 subjects. Data for the change score in depressive symptoms over time (see section 'depressive symptoms' below) were available for 1853 subjects.
Onset of Chronic Multisite Musculoskeletal Pain
Chronic multisite musculoskeletal pain was measured using an updated version of the Chronic Pain Grade (CPG). 25 Previous studies have shown that the internal consistency of the CPG is good (Cronbach's α > 0.9). 27 The CPG has been validated against the SF-36, and acceptable and significant correlations were found. 26, 27 The CPG first inquires about the presence of pain in the prior 6 months in the extremities (joints of the arms, hands, legs, or feet), back, neck, head, abdomen, chest, and the orofacial area (mouth and face). 25 The subsequent questions in the CPG refer to the most painful location and inquire (1) days in pain in the prior 6 months (scale 0-180); (2) pain at this moment (scale 0-10); (3) worst pain in the prior 6 months (scale 0-10); (4) average pain in the prior 6 months (scale 0-10); (5) disability days in the prior 6 months (scale 0-180); (6) disability in daily activities (scale 0-10); (7) disability in spare time, social life, and family activities (scale 0-10); and (8) disability in work (scale 0-10). A total pain intensity score was calculated using questions on present pain as well as worst and average pain in the prior 6 months (Questions 2, 3 and 4 of the CPG). A total pain disability score was calculated using questions on disability in the prior 6 months (Questions 6, 7, and 8 of the CPG). For both total scores, the average of the 0-10 ratings of the three questions were multiplied by 10 resulting in a 0-100 score. Disability points (7 categories; 0-6) were calculated adding the total disability score (0-100) and the indicated points for disability days (question 5 of the CPG; see 28 28 for more details). Following our previous work, [29] [30] [31] we defined chronic multisite musculoskeletal pain as grade I, II, III, or IV on the CPG and pain present in the extremities, the back, and the neck. Participants were classified as having onset of chronic multisite musculoskeletal pain if they met these criteria at one of the follow-up assessments (2 years, 4 years, or 6 years). We further refer to chronic multisite musculoskeletal pain as "chronic pain."
Insomnia and Sleep Duration
Sleep was assessed by insomnia and sleep duration as part of a questionnaire that participants filled out after the interview at the research site or later at home (median time log for returning the questionnaire was 4 days). Insomnia, defined as a subjective report of problems initiating or maintaining sleep, was measured using the Women's Health Initiative Insomnia Rating Scale (IRS), a valid and reliable questionnaire to assess sleep complaints. 32 Previous research has shown that the internal consistency of the IRS is acceptable (α = 0.786) and that test-retest correlation is high (same day = .96, more than 1 year later = .66). 32 The IRS has also been validated against more objective sleep measurements (sleep latency, sleep efficiency, and wake time after sleep onset as measured with an actigraph). Correlations were small but statistically significant and in the expected directions. 32 The IRS consists of five questions concerning sleep in the past month. The five questions address trouble falling asleep, waking up during the night, early morning awakenings, trouble getting back to sleep after waking up, and sleep quality. Scores on the first 4 items range from 0 "no" to 4 "≥5 times a week." The fifth item of sleep quality ranges from 0 "very sound or restful" to 4 "very restless." The total summary score ranges from 0 "no insomnia" to 20 "severe insomnia." In line with previous research, 32, 33 scores on the IRS were dichotomized at a cutoff point of nine, which has shown to indicate clinical significant insomnia. Sleep duration was assessed by asking participants to estimate the average hours of sleep per night during the past month, ranging from less than 5 hr to more than 10 hr. Following previous findings for depression and anxiety, 34 we anticipated that both short and long sleep may have deleterious effects on pain. Therefore, sleep duration was categorized as short (≤6 hours), normal (7-9 hours), and long (≥10 hours).
Depressive Symptoms
Severity of depressive symptoms in the week prior to the interview (at baseline and at 2, 4, and 6 years of follow-up) was measured with the Inventory of Depressive Symptomatology (IDS), 35 a valid and reliable instrument (see 36 for psychometric properties). The IDS consists of 30 items, with each item rated on a 4-point scale. Either appetite increase or decrease, but not both, is used to calculate the total score. Likewise, weight increase or decrease, but not both, are used to calculate the total score. 35 The IDS contains 4 sleep-related items, which we excluded for the present study. Therefore, the total IDS scale score ranges between 0 and 72, with higher scores indicating a higher severity. Depressive symptoms were analyzed as a baseline score and as a change score from baseline until the moment a subject had an event, onset of chronic pain, or was censored at the last recorded follow-up. In case follow-up data on depressive symptoms were missing at 4-or 6-year of follow-up, the value for depressive symptoms at 2-or 4-year follow-up (respectively) was used for calculation of the depression change score (last observation carried forward, n = 51).
Covariates
Baseline covariates were selected a priori based on previous studies on sleep, depression, and chronic pain. 22 39 Physical activity was assessed with the International Physical Activity Questionnaire and expressed as one's resting metabolic rate multiplied by minutes of physical activity per week (reported as 1000 MET-minutes per week). 40 Following previous research, 41 we assessed the total number of chronic somatic diseases (including cardiometabolic, respiratory, musculoskeletal, gastrointestinal, neurological, endocrine diseases, and cancer) by self-report for which persons were under treatment.
Frequent use (daily or >50% of the time) of medication was assessed based on drug container inspection of all drugs used in the past month and classified according to the World Health Organization Anatomical Therapeutic Chemical (ATC) classification. 42 Sleep medication included benzodiazepines (ATC codes: N05BA/CF/CD and N03AE). Antidepressant medication included tricyclic antidepressants (ATC code: N06AA), selective serotonin reuptake inhibitors (ATC code: N06AB), and other antidepressants (ATC codes: N06AF/AG/AX). Pain medication included analgesic medication (ATC codes: M01, M03, N02 and N03AF01/AX12/AX16). Anxiety disorders were included as a covariate as they might also impact on the association of insomnia and/or sleep duration with chronic pain onset. 37, 38 The presence of both current and prior diagnoses of anxiety disorders, including panic disorder, agoraphobia, 
Statistical Analyses
Baseline characteristics were compared between subjects with and without onset of chronic pain using independent-samples t tests for continuous variables, chi-square tests for dichotomous and categorical variables, and Mann-Whitney U tests for nonnormally distributed variables. Cox's regression analyses were performed to determine the independent associations of insomnia and sleep duration at baseline with the onset of chronic pain over 6-year follow-up while adjusting for sociodemographic variables (age, sex, and years of education) and lifestyle and health variables (body mass index, smoking, alcohol intake, physical activity, and the number of chronic diseases). Time at risk was measured from baseline until the moment a person had an event, onset of chronic pain, or was censored at the last recorded follow-up. Proportional hazards were verified. Several sensitivity analyses were performed for the models also including all basic covariates. First, since pain status at baseline might influence both sleep at baseline and chronic pain at follow-up, 44 we additionally adjusted our analyses for pain intensity at baseline. Second, to discard any potential confounding effects of medication intake in our study, we additionally adjusted our analyses for sleep medication, antidepressants, and pain medication. Third, analyses were additionally adjusted for the presence of anxiety disorders. Fourth, insomnia and sleep duration are only moderately correlated (Spearman r = 0.36, p ≤ .001 in our sample), which is in line with the notion that they are partially separate concepts. 45 Nevertheless, we checked whether our findings for insomnia and sleep duration were independent of each other by including them simultaneously in one model.
Mediation analyses were performed to test whether the associations between baseline insomnia and/or sleep duration and chronic pain onset were mediated by depressive symptoms. We applied the Preacher and Hayes's SPSS macro "process," which allows the use of dichotomous outcomes. 46 Both baseline depressive symptoms and a change score of depressive symptoms over time were considered as potential mediators. Values for both depression scores were divided by 10 to create comparable effect sizes. Onset of chronic pain was considered as a non-time-dependent dichotomous outcome variable in the mediation analyses. For ease of interpretation, sleep duration was considered as a dichotomous predictor (short sleep vs. normal and long sleep). First, we tested direct associations of insomnia (Figures 1 and 3 ) and short sleep duration (Figures 2 and 4 ) with chronic pain onset using logistic regression analyses (c). Next, we applied mediation analyses to test (1) the effect of insomnia and short sleep duration on depressive symptoms (a); (2) the effect of depressive symptoms on chronic pain onset (b); (3) the direct effect of insomnia and short sleep duration on chronic pain onset, corrected for a × b (c'); (4) the indirect effect of insomnia and short sleep duration on chronic pain onset through depressive symptoms (a × b). Mediation analyses were adjusted for all confounders (similar to Table 2 ). Analyses for the depression change score were additionally adjusted for baseline depressive symptoms. We calculated the change in the unstandardized effect size (∆B) by subtracting c' from c and dividing this residual by the c (∆B = (c − c')/c). This method estimates the indirect effect of the independent variable on the dependent variable through the mediator variable. The macro uses bootstrap resampling procedures, in which subjects are randomly selected, with replacement, from the original sample. For each bootstrap sample, the model is estimated and the parameters saved. The indirect effect is deemed significant if the 95% bootstrap percentile confidence interval did not include zero. Number of bootstraps were set at 5000.
For all statistical tests, a probability level of ≤5% was regarded as significant. The statistical calculations were performed using SPSS version 20.0 for Windows (IBM Corp., Armonk, NY, USA).
RESULTS
Of 1860 subjects, 11% developed chronic pain over 2 years, 17% over 4 years, and 21% over 6 years. Persons who developed chronic pain were significantly older, were more often female, were less educated, had higher pain scores at baseline, had a higher body mass index, had more chronic diseases, had higher depressive symptoms scores, had more often insomnia, and had more often short or long sleep duration (see Table 1 for baseline characteristics, all p < .05).
Persons with baseline insomnia (n = 726) had higher baseline pain intensity scores than subjects without baseline insomnia (n = 1130; mean (SD) = 40. 
Insomnia, Sleep Duration, and Chronic Pain Onset
Insomnia and short sleep duration at baseline were significantly associated with a higher hazard of chronic pain onset over 6 years after adjustment for basic covariates (insomnia: hazard ratio [ In order to discard the potential effect of frequent pain medication intake (±9.3%) on the selection of our subjects free of chronic pain, we performed additional analyses only including subjects without frequent pain medication intake at baseline (n = 1687) and found similar and significant associations for insomnia and short sleep with chronic pain onset (insomnia: 
Mediation by Baseline Depressive Symptoms
Compared to the direct associations of insomnia and short sleep with chronic pain onset ( Table 2) , mediation analyses for baseline depression ( Figure 1 and Figure 2) showed similar significant associations for insomnia and short sleep with chronic pain onset over 6 years, insomnia: B (SE) = 0.53 (0.12), p < .001; short sleep: B (SE) = 0.47 (0.13), p < .001; see upper part (c). Both insomnia and short sleep appeared significantly associated with baseline depressive symptoms, insomnia: B (SE) = 1.00 (0.05), p < .001; short sleep: B (SE) = 0.49 (0.06), p < .001; (a). Our analyses also showed that baseline depressive symptoms were associated with chronic pain onset in both models, insomnia: B(SE) = 0.22 (0.05), p = .001; short sleep: B (SE) = 0.25 (0.05), p < .001; (b). Direct effects of insomnia and short sleep with chronic pain onset attenuated when adding baseline depressive symptoms as a mediator to the models (insomnia: ∆B = 40%; short sleep: ∆B = 26%). However, these direct effects remained statistically significant, insomnia: B (SE) = 0.32 (0.13), p = .01; short sleep: B (SE) = 0.35 (0.15), p = .01; see (c') in Figure 1 and Figure 2 . Thus, the associations of insomnia and short sleep with chronic pain onset seem to be partially mediated by baseline depressive symptoms.
Mediation by Change in Depressive Symptoms
Further mediation by the depression change score was tested in a model already including baseline depressive symptoms ( Figure 3 and Figure 4 ). Therefore, (c) corresponds to the direct effect (c') of the mediation models presented in Figures 1 and  2 . Analyses for the depression change score similarly showed significant effects of insomnia and short sleep with chronic pain onset over 6 years, insomnia: B (SE) = 0.32 (0.13), p = .01; short sleep: B (SE) = 0.35 (0.13), p = .009; see upper part (c). While insomnia was significantly associated with an increase in depressive symptoms over time, B (SE) = 0.11 (0.04), p = .007; (a), this was not the case for short sleep duration, B (SE) = 0.05 (0.04), p = .25; (a). However, an increase in depressive symptoms did appear significantly associated with chronic pain onset in both models, insomnia: B (SE) = 0.42 (0.07), p < .001; short sleep: B (SE) = 0.43 (0.07), p < .001; (b). The direct effect between insomnia and chronic pain onset significantly attenuated when adding the depression change score as a mediator to the model (∆B = 16%), although this was not the case for short sleep duration, ∆B = 3%; indirect effect (a × b): p = .33. Similar to the analyses for baseline depression, direct effects for both insomnia and short sleep with chronic pain onset remained statistically significant, insomnia: B (SE) = 0.27 (0.13), p = .04; short sleep: B (SE) = 0.34 (0.14), p = .01; see (c') in Figures  3 and 4 . Thus, an increase in depressive symptoms seems to partially mediate the association for insomnia, but not for short sleep, with chronic pain onset.
DISCUSSION
This longitudinal study showed that insomnia, short sleep duration, baseline depressive symptoms, and a further increase in depressive symptoms over time were independent predictors of the onset of chronic pain over 6 years. The effect for insomnia and short sleep with chronic pain onset seems to be partially mediated by depressive symptoms.
Our finding that disturbed sleep is a risk factor for developing chronic pain is in line with previous prospective studies. [5] [6] [7] [8] [9] [10] [11] In line with our hypothesis, 16, 22 the associations of insomnia and short sleep with chronic pain onset seem partially mediated by baseline depressive symptoms (∆B = 40% and 26%, respectively), although an independent effect of insomnia and short sleep with chronic pain remains. Insomnia and short sleep are highly disabling and may result in increased levels of arousal 22 and neurobiological changes. 47 Our study suggests that disturbed sleep might subsequently lead to negative mood and other associated symptoms, ultimately resulting in a transition from acute to chronic pain. The association between insomnia (but not short sleep) and chronic pain was further attenuated by adjusting for a change in depressive symptoms over time (∆B = 16%). Thus, we found evidence that a further increase in depressive symptoms over time contributes to the link between insomnia and chronic pain. This suggests that not sleep quantity but rather sleep quality and difficulties initiating or maintaining sleep could worsen a person's depressive symptoms over time. These symptoms may ultimately contribute to the onset of chronic pain, most likely by deteriorating central sensitization.
A few previous cross-sectional studies [48] [49] [50] and prospective multivariable studies [6] [7] [8] adjusted for the influence of depression and also demonstrated an independent effect between sleep and pain. However, while depression indicates impaired mental health, our study assessed depressive symptoms which is as a more general reflection of negative mood. Baseline depressive symptoms and an increase in depressive symptoms over time independently predict the onset of chronic pain in our study, which concurs with multiple previous studies. 37, [51] [52] [53] Thus, our findings indicate that both poor sleep and depressive symptoms or a proxy of negative mood may contribute to the process of central sensitization, ultimately resulting in chronic pain. This supports the notion that subjects with sleep problems and Figure 1 -Illustration of the total effect of insomnia on chronic pain onset over 6 years (c) and a mediation design where insomnia affects chronic pain onset directly (c') and indirectly (a × b) through baseline depressive symptoms (n = 1851). *p < .05; **p < .01; ***p < .001. Direct effect: ∆B = -40%. c = original effect of insomnia on chronic pain onset over 6 years; a = effect of insomnia on depressive symptoms; b = effect of depressive symptoms on chronic pain onset; a × b = indirect effect of insomnia on chronic pain onset; c' = direct effect of insomnia on chronic pain onset in mediation design. Baseline depression: B per 10 points increase. Analyses were adjusted for sex, age, years of education, body mass index, smoking, alcohol intake, physical activity, and number of chronic diseases. concurrent depressive symptoms report the highest levels of pain, but sleep problems in the absence of depressive symptoms also increases pain. 49 Therefore, both sleep and depressive symptoms should be addressed as part of the etiology of chronic pain. 54 Several mechanisms have emerged as potential pathways linking sleep to chronic pain, although they are speculative. Previous studies found that altered function of the hypothalamic-pituitary-adrenal axis (HPA-axis) and the immune system were associated with both sleep complaints 55, 56 and chronic Figure 3-Illustration of the total effect of insomnia on chronic pain onset over 6 years (c) and a mediation design where insomnia affects chronic pain onset directly (c') and indirectly (a × b) through change in depressive symptoms over time (n = 1849). *p < .05; **p < .01; ***p < .001; Direct effect: ∆B = -16%. c = original effect of insomnia on chronic pain onset over 6 years; a = effect of insomnia on change in depressive symptoms; b = effect of change in depressive symptoms on chronic pain onset; a × b = indirect effect of insomnia on chronic pain onset; c' = direct effect of insomnia on chronic pain onset in mediation design. Change in depression: B per 10 points increase in change score of depressive symptoms (positive score indicates worsening of symptoms). Analyses were adjusted for sex, age, years of education, body mass index, smoking, alcohol intake, physical activity, number of chronic diseases, and baseline score of depressive symptoms.
pain. 57 However, our previous NESDA study (n = 2039) showed that function of the HPA-axis, the immune system, and the autonomic nervous system was not associated with chronic pain onset, 29 which suggests other biological pathways may better explain the sleep-pain relationship. Evidence, mainly from animal studies, proposed opioidergic, serotonergic, and dopaminergic neurotransmitter systems 16, [58] [59] [60] to explain the link between sleep deprivation and hypersensitivity to pain. In addition, a negative affective coping style related to the pain, such as catastrophizing, has been found to mediate between insomnia and central sensitization. 16, 61 Also, the link between sleep and pain might be explained by higher levels of presleep arousal in subjects vulnerable to chronic pain, suggesting it is not poor sleep per se but rather high levels of distress that increase the risk of developing chronic pain. 62 Another study suggests that increased attention to pain may be a mediator between poor sleep and pain. 63 It remains for future prospective studies to examine these potential biological and psychosocial pathways to be better able to predict chronic pain onset. In addition, it is likely that sleep, depressive symptoms, and pain are mutually interactive, each inducing or perpetuating the other. 17, 23 This is supported by the notion that all three conditions seem to be principally regulated by central nervous system factors [64] [65] [66] and are aggravated by exposure to life stress. 29, 67, 68 We found that short sleep duration, but not long sleep duration, predicted chronic pain onset. This is in contrast to the hypothesis that extensive sleep negatively affects health, 34 but in line with other studies suggesting that short sleep negatively affects pain. 69 Perhaps the sample size of persons with long sleep duration was too small to be able to show this; long sleepers in our study were more frequently lost to follow-up. Another explanation is that short sleep duration is a marker of health status, whereas long sleep may be the result of longstanding disease processes such as certain types of depressive and anxiety disorders. 36 Also, it could be that muscles cannot recover sufficiently in the case of short sleep 9 and that this is not the case for long sleep, although this warrants further research. Strong aspects of this study are the longitudinal design, the large sample size, and the assessment of both sleep quality and quantity in relation to chronic pain onset while adjusting for several covariates such as lifestyle. The NESDA study contains a high proportion of subjects with sleep disturbances and with the onset of chronic multisite musculoskeletal pain, which makes it a very suitable sample to study their relationship. Our participants show sufficient variation in depressive symptoms scores, enabling us to examine the influence of this relevant covariate. Next to these important strengths, there are also several methodological considerations to our study. First, this observational study was not designed to definitely prove mediation by depressive symptoms. Second, self-report of sleep may differ from more objective measures of sleep, such as polysomnography or actigraphy. Perhaps the self-experience of sleep rather than objective sleep is predictive of chronic pain onset. On the other hand, the insomnia rating scale has been validated against actigraphy measures for women. 32 Third, it is likely that the most vulnerable subjects in our study were lost to follow-up. On the other hand, we still found significant associations for insomnia, short sleep, and depressive symptoms with future chronic pain onset. Fourth, our classification of chronic multisite musculoskeletal pain was self-reported pain in the extremities, the back and the neck in the prior 6 months. Pain may strongly fluctuate, and we only assessed pain at four Figure 4 -Illustration of the total effect of short sleep duration on chronic pain onset over 6 years (c) and a mediation design where short sleep duration affects chronic pain onset directly (c') and indirectly (a × b) through change in depressive symptoms over time (n = 1852). *p < .05; **p < .01; ***p < .001; Direct effect: ∆B = -3%. c = original effect of short sleep (vs. normal and long sleep) on chronic pain onset over 2 years; a = effect of short sleep on change in depressive symptoms; b = effect of change in depressive symptoms on chronic pain onset; a × b = indirect effect of short sleep on chronic pain onset; c' = direct effect of short sleep on chronic pain onset in mediation design. Change in depression: B per 10 points increase in change score of depressive symptoms (positive score indicates worsening of symptoms). Analyses were adjusted for sex, age, years of education, body mass index, smoking, alcohol intake, physical activity, number of chronic diseases, and baseline score of depressive symptoms.
separate time points throughout follow-up of 6 years. Also, our findings might differ for other types of pain. Previous studies mostly investigated chronic widespread pain, which is a cardinal symptom of the fibromyalgia syndrome and defined as axial and bilateral pain above and below the waist. 70 With our "less stringent" definition, we may have included patients with milder pain complaints. However, the majority of multisite pain patients do not fulfill the "widespread" criteria but still suffer from high pain intensity, significant psychological distress, and severe limitations in daily living. 71 Therefore, setting somewhat broader parameters for studying the etiology of chronic pain might be useful. 71, 72 In conclusion, this longitudinal study shows that insomnia, short sleep, and depressive symptoms might trigger the development of chronic pain. The association for insomnia and short sleep with chronic pain onset seems to be partially mediated by depressive symptoms.
